Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
dievini Hopp Biotech Holding
AddedFeb 15, 2024
UpdatedJun 28, 2026
dievini Hopp Biotech Holding

dievini Hopp Biotech Holding

Dievini, a German-based investor, focuses on innovative therapeutics and diagnostics in Life and Health Sciences, primarily in personalized medicine.

HQ
Walldorf, Baden-Württemberg, DE
Founded
2005
Overview
Compare
Employees
Website

Founded in Walldorf, Baden-Württemberg, Germany, Dievini Hopp Biotech Holding is an active investor specializing in Life and Health Sciences. The company’s core mission is to support and coach management teams in corporate and business development, with a vision to advance innovative therapeutics and diagnostics. Dievini primarily invests in companies that develop unique and first-in-class treatments and diagnostic tools, aiming to enhance personalized medicine and improve the safety and efficacy of treatments for life-threatening diseases.

Notable affiliates include co-founder Dietmar Hopp, a prominent entrepreneur and philanthropist. Dievini has made significant investments in several groundbreaking biotech firms, contributing to advancements in personalized medicine. The company’s impact is evident through its support of pioneering therapies and diagnostics, which have led to novel treatment regimens that improve patient outcomes. Through strategic investments and active mentorship, Dievini continues to drive innovation in the healthcare sector.

dievini Hopp Biotech Holding - Quick Facts

When was dievini Hopp Biotech Holding founded?

dievini Hopp Biotech Holding was founded in 2005.

Where is dievini Hopp Biotech Holding's headquarters located?

dievini Hopp Biotech Holding's headquarters is located in Walldorf, Baden-Württemberg, DE.

How many employees does dievini Hopp Biotech Holding have?

dievini Hopp Biotech Holding has 8 employees as of Feb 4, 2024.

dievini Hopp Biotech Holding - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Europe
Model
  • Platform
Customer
  • Enterprise
Main Product
  • Diagnostics
  • Therapeutics
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software